Saturday, April 1, 2023

Enhance Diagnostic Accuracy with Imaging Biometrics' IB Neuro™ v2.0 on Medimsight Platform

Discover how Imaging Biometrics' IB Neuro™ v2.0, available on the Medimsight platform, can streamline the analysis of dynamically acquired MR and CT datasets, generate parametric perfusion maps, and integrate seamlessly into existing medical imaging workflows for doctors, radiologists, and biomedical engineers in clinical trials, basic research, and clinical practice.

Perfusion imaging is a crucial component in diagnosing and treating various neurological disorders such as stroke, brain tumors, and vascular malformations. For doctors, radiologists, and biomedical engineers working in clinical trials, basic research, and clinical practice, having access to accurate and reliable perfusion analysis tools is essential for effective patient care.

Imaging Biometrics' IB Neuro™ v2.0, available on the Medimsight platform, is designed to address the advanced clinical and research needs of medical professionals by analyzing dynamically acquired MR and CT datasets and generating parametric perfusion maps that quantify changes in contrast over time. This cutting-edge solution offers several key features that can enhance diagnostic accuracy and streamline the analysis process.

One of the main advancements in IB Neuro™ v2.0 is its improved automatic generation of Arterial Input Function (AIF), which is vital for accurate perfusion analysis. Furthermore, the software allows for rapid creation of a complete array of critical perfusion parameter maps, including Time-to-Peak (TTP) and Tmax, providing medical professionals with valuable insights into the perfusion status of brain tissue. In addition, the software automatically corrects for contrast agent leakage across the blood-brain barrier in MR DSC, further enhancing the accuracy of the perfusion analysis.

The Voxel Intensity Calibration™ technology, exclusive to Imaging Biometrics, allows for the standardization and normalization of parameters, ensuring consistent comparison between different studies.

With dual-echo GRE support for MR DSC and seamless integration with existing medical image visualization applications, IB Neuro™ v2.0 is an invaluable tool for medical professionals who require advanced, reliable, and user-friendly perfusion analysis software.

In conclusion, Imaging Biometrics' IB Neuro™ v2.0, available on the Medimsight platform, empowers doctors, radiologists, and biomedical engineers to make more accurate diagnoses and treatment decisions for patients with neurological disorders. By providing a comprehensive array of perfusion parameters and cutting-edge features, IB Neuro™ v2.0 is an essential tool for medical professionals striving to enhance patient care in clinical trials, basic research, and clinical practice.

Visit the Medimsight marketplace at https://www.medimsight.com/apps to learn more about Imaging Biometrics' IB Neuro™ v2.0 and other advanced imaging solutions available on the platform.